IPP Bureau

Venus Remedies join AMR alliance to combat global health threat
Venus Remedies join AMR alliance to combat global health threat

By IPP Bureau - February 07, 2022

The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry

Rahul Guha to join Thyrocare Technologies as MD & CEO
Rahul Guha to join Thyrocare Technologies as MD & CEO

By IPP Bureau - February 07, 2022

Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice

WHO Goodwill Ambassador calls for renewed focus on leprosy
WHO Goodwill Ambassador calls for renewed focus on leprosy

By IPP Bureau - February 07, 2022

The campaign aims to bring back focus on leprosy case detection, treatment and rehabilitation; especially in the context of neglect brought in by Covid-19 pandemic

Redcliffe Labs appoints Abhay Singavi as Chief Business Officer
Redcliffe Labs appoints Abhay Singavi as Chief Business Officer

By IPP Bureau - February 07, 2022

Takes charge to lead business innovation, strategy, alliance & partnerships

Serum receives green light for Omicron variant vaccine
Serum receives green light for Omicron variant vaccine

By IPP Bureau - February 07, 2022

Pfizer and Moderna are also working on vaccines that target the Omicron variant

Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore
Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore

By IPP Bureau - February 05, 2022

Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021

Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crore
Sun Pharma Advanced Research Company Q3FY22 loss at Rs. 15.84 crore

By IPP Bureau - February 05, 2022

Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021

IOL Chemicals and Pharmaceuticals Q3FY22 PAT at Rs. 40.07 crore
IOL Chemicals and Pharmaceuticals Q3FY22 PAT at Rs. 40.07 crore

By IPP Bureau - February 05, 2022

IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021

Dishman Carbogen Amcis Q3FY22 PAT at Rs. 35.38 crore
Dishman Carbogen Amcis Q3FY22 PAT at Rs. 35.38 crore

By IPP Bureau - February 05, 2022

Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021

Sanofi unveils new corporate brand and logo
Sanofi unveils new corporate brand and logo

By IPP Bureau - February 05, 2022

Sanofi unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019

Expert panel recommends Emergency Use Authorisation for Sputnik Light
Expert panel recommends Emergency Use Authorisation for Sputnik Light

By IPP Bureau - February 05, 2022

The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval

Indian govt. places order for five crore doses of Corbevax
Indian govt. places order for five crore doses of Corbevax

By IPP Bureau - February 05, 2022

Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius

Lupin Q3FY22 PAT at Rs 545.52 cr.
Lupin Q3FY22 PAT at Rs 545.52 cr.

By IPP Bureau - February 04, 2022

Lupin has reported consolidated financial results for the period ended December 31, 2021

Pfizer Q3FY22 PAT at Rs 143.91 crore
Pfizer Q3FY22 PAT at Rs 143.91 crore

By IPP Bureau - February 04, 2022

The company has reported standalone financial results for the period ended December 31, 2021.

Sun Pharma demonstrates strong performance on all fronts: ICICI Direct
Sun Pharma demonstrates strong performance on all fronts: ICICI Direct

By IPP Bureau - February 04, 2022

Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses

Latest Stories

Interviews

Packaging